Picture Swiss Biotech Association LSG Swiss Biotech Days 2025 Basel 650x100px

Product › Details

Ocrevus®

	Next higher product group	ocrelizumab
	Status	2017-03-29 registration start
	Organisation	Roche (Group)
	Organisation 2	Biogen Idec (Group)
	Today	Biogen (Group)
	Group	Biogen (Group)

Record changed: 2024-07-25

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Agenda 650x100px

More documents for antibody

[1] Pierre Fabre Laboratories. (3/12/25). "Press Release: Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership". Castres, Cambridge, MA & Basel....
[2] Bambusa Therapeutics, Inc.. (2/14/25). "Press Release: Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases". Boston, MA....
[3] BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg....
[4] Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried....
[5] Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA....
[6] Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets"....
[7] Epsilogen Ltd.. (9/9/24). "Press Release: Epsilogen Completes £12.5 Million Series B Financing Expansion". London....
[8] Bambusa Therapeutics, Inc.. (9/9/24). "Press Release: Bambusa Therapeutics Inc. Announces Successful Series Seed Funding to Advance Innovative Bispecific Antibodies for Immunology & Inflammation". Boston, MA....
[9] Immunic, Inc.. (7/24/24). "Press Release: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec". New York, NY....
[10] Sotio Biotech a.s.. (7/16/24). "Press Release: Sotio Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline". Prague & Beijing....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)